PHARMEDOX LIMITED

Follow this company
Executive Summary

PHARMEDOX LIMITED operates in the high-innovation biotechnology R&D sector but remains dormant with negligible financial activity since incorporation. Its current status places it outside typical industry operational benchmarks, reflecting a pre-startup phase. Future competitive positioning will depend on its ability to engage actively in R&D and secure funding amidst a dynamic and capital-intensive market environment.

View Full Analysis Report →

Who controls this company?

Dr. Keith Alfred Moyse

Correspondence address
49, William Morris Close, Oxford, England, OX4 2JX
Date of birth
August 1955
Notified on
2021-09-27
Nationality
British
Country of residence
England
 
Source data
Nature of control
Owns more than 75% of the company's shares
Has more than 75% of the voting rights in the company
More Company Information
Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
    • Follow this company